The release of two key draft FDA Guidances on abuse liability assessments on drugs* and abuse-deterrent products has resulted in increased demand for human abuse liability studies. In response, Cambridge Cognition, the global leader in touchscreen cognitive assessments for clinical trials, has formed a scientific partnership with Altreos Research Partners, Inc., a leading provider of scientific, regulatory and operational input on abuse liability assessments.
20 August, 2014
Converting stem cell data into sounds could enable GPs to make instant, non-invasive cancer diagnoses during a routine check-up.With waiting times for cancer tests at a six-year high, this could significantly reduce the agonising and potentially life-threatening wait for patients and improve Government waiting time targets.*
18 August, 2014
The largest ever genome wide association study on hearing ability has identified the salt-inducible kinase 3 (SIK3) gene as a key influencer in how well we can hear, particularly at high frequencies. This significant new finding by King's College London, co-funded by charities Action on Hearing Loss and Age UK, increases the understanding of the causes of hearing loss, which affects 10 million people in the UK and could lead to future treatments.
15 August, 2014
Like a self-assembling ‘Lego Death Star’, says lead researcher
14 August, 2014
It has been more than 20 years since scientists discovered that mutations in the gene huntingtin cause the devastating progressive neurological condition Huntington’s disease, which involves involuntary movements, emotional disturbance and cognitive impairment. Surprisingly little, however, has been known about the gene’s role in normal brain activity.
13 August, 2014